Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells

被引:82
作者
Svehlíková, V [1 ]
Wang, SR [1 ]
Jakubíková, J [1 ]
Williamson, G [1 ]
Mithen, R [1 ]
Bao, YP [1 ]
机构
[1] Inst Food Res, Inst Food Res, Div Nutr, Norwich NR4 7UA, Norfolk, England
基金
英国生物技术与生命科学研究理事会;
关键词
D O I
10.1093/carcin/bgh169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The isothiocyanate, sulforaphane and the flavonoid, apigenin modulate gene expression including phase II detoxifying enzymes, such as glutathione S-transferases (GST) and UDP-glucuronosyltransferases (UGT). Using undifferentiated CaCo-2 cells, we have examined the interactions between sulforaphane and apigenin in the regulation of UGT and GST expression. We show that apigenin induces UGT1A1 transcription (4-fold) but not GSTA1, and that sulforaphane induces both UGT1A1 (3.7-fold) and GSTA1 (2.8-fold) transcription in both dose- and time-dependent manners. The combination of sulforaphane and apigenin resulted in a synergistic induction of UGT1A1 mRNA up to 12-fold, although this interaction was not seen for GSTA1. Nuclear factor kappa B (NF-kappaB) mRNA was induced by apigenin and sulforaphane (2.5- and 2-fold, respectively). NF-kappaB translocation inhibitor SN50 and phosphatidylinositol 3-kinase (PI3) inhibitor LY294002 decreased the induction of GSTA1 by sulforaphane almost to baseline level. However, the MEK inhibitor PD98059 enhanced significantly the induction of GSTA1 by sulforaphane. This suggests that NF-kappaB and PI3-kinase signaling pathways play a role in GSTA1 gene expression. Conversely, the induction of UGT1A1 transcription by sulforaphane was totally abolished by PD98059, although PD98059 slightly enhanced (20%) the induction of UGT1A1 by apigenin implying that the induction of UGT1A1 by sulforaphane is mediated by MAPK/extracellular signal-regulated kinase kinase, whereas UGT1A1 induction by apigenin may be associated with NF-kappaB translocation since the NF-kappaB translocation inhibitor, SN50 enhanced the induction of UGT by apigenin. The results show that UGT1A1 and GSTA1 are regulated by sulforaphane through different signal transduction pathways and the differences in the mechanisms of modulation of UGT1A1 transcription by sulforaphane and apigenin resulted in a synergistic effect between these two compounds in the induction of UGT1A1.
引用
收藏
页码:1629 / 1637
页数:9
相关论文
共 61 条
[1]   Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition [J].
Agullo, G ;
GametPayrastre, L ;
Manenti, S ;
Viala, C ;
Remesy, C ;
Chap, H ;
Payrastre, B .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (11) :1649-1657
[2]   Sulforaphane and quercetin modulate PhIP-DNA adduct formation in human HepG2 cells and hepatocytes [J].
Bacon, JR ;
Williamson, G ;
Garner, RC ;
Lappin, G ;
Langouët, S ;
Bao, YP .
CARCINOGENESIS, 2003, 24 (12) :1903-1911
[3]   Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) in cultured cells [J].
Basten, GP ;
Bao, YP ;
Williamson, G .
CARCINOGENESIS, 2002, 23 (08) :1399-1404
[4]   Activation of the mouse TATA-less and human TATA-containing UDP-glucuronosyltransferase 1A1 promoters by hepatocyte nuclear factor 1 [J].
Bernard, P ;
Goudonnet, H ;
Artur, Y ;
Desvergne, B ;
Wahli, W .
MOLECULAR PHARMACOLOGY, 1999, 56 (03) :526-536
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]  
Chiao JW, 2002, INT J ONCOL, V20, P631
[7]   The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk [J].
Coles, B ;
Nowell, SA ;
MacLeod, SL ;
Sweeney, C ;
Lang, NP ;
Kadlubar, FF .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2001, 482 (1-2) :3-10
[8]   Interindividual variation and organ-specific patterns of glutathione S-transferase alpha, mu, and pi expression in gastrointestinal tract mucosa of normal individuals [J].
Coles, BF ;
Chen, GP ;
Kadlubar, FF ;
Radominska-Pandya, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 403 (02) :270-276
[9]  
Delie F, 1997, CRIT REV THER DRUG, V14, P221
[10]  
*DEP HLTH, 1998, NUTR ASP DEV CANC